Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-01-23T18:25:29.016Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychopharmacology of Obsessive-Compulsive Disorder

Published online by Cambridge University Press:  07 November 2014

Stuart A. Montgomery
Get access Rights & Permissions [Opens in a new window]

Extract

Obsessive-compulsive disorder (OCD) was thought to be a rather rare disorder and little attention was focused on investigations of the disorder until the first placebo-controlled studies reported efficacy. In 1980 three pivotal papers were published: Montgomery reported that clomipramine was effective in OCD without concomitant depression, and Thoren et al and Marks et al reported that clomipramine was effective in OCD with varying amounts of concomitant depression. These results opened the floodgates of psychopharmacological research and encouraged a more aggressive research program aimed at providing sufficient data for OCD to be recognized as a treatable condition.

Type
Supplement Monograph
Information
CNS Spectrums , Volume 3 , Issue S1: New Developments in Obsessive-Compulsive and Spectrum Disorders , May 1998 , pp. 33 - 37
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Montgomery, SA. Clomipramine in obsessional neurosis: a placebo controlled trial. Pharmaceut Med. 1980;189–192.Google Scholar
2.Thoren, P, Asberg, M, Cronholm, B, Jornestedt, L, Traskman, L. Clomipramine treatment in obsessive compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry. 1980;37:1281–1285.Google Scholar
3.Marks, IM, Stern, RS, Mawson, D, Cobb, J, McDonald, R. Clomipramine and exposure for obsessive compulsive rituals. Br J Psychiatry. 1980;136:1–25.Google Scholar
4.McDougle, CJ, Goodman, WK, Price, LH, et al.Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990;147:652–654.Google Scholar
5.Goodman, WK, Price, LH, Rasmussen, SA, Delgado, PL, Heninger, GR, Charney, DS. Efficacy of fluvoxamine in obsessive compulsive disorder. Arch Gen Psychiatry. 1989;46:36–44.CrossRefGoogle ScholarPubMed
6.Perse, TL, Greist, JH, Jefferson, JW, Rosenfeld, JW, Dar, R. Fluvoxamine treatment of obsessive compulsive disorder. Am J Psychiatry. 1987;144:1543–1548.Google Scholar
7.Goodman, WK, Kozak, MJ, Liebowitz, M, White, KL. Treatment of obsessive-compulsive disorder with fluvoxamine:a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol. 1996;11:21–30.Google Scholar
8.Montgomery, SA, Manceaux, A. Fluvoxamine in the treatment of obsessive compulsive disorder. Int Clin Psychopharmacol. 1992;7(Suppl 1):5–9.CrossRefGoogle ScholarPubMed
9.Montgomery, SA, McIntyre, A, Osterheider, M, et al, and The Lilly European OCD Study Group. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive compulsive disorder. Eur Neuropsychopharmacol. 1993;3:143–152.Google Scholar
10.Tollefson, GD, Rampey, AH, Potvin, JH, et al.A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51:559–567.Google Scholar
11.Greist, J, Chouinard, G, DuBoff, E, et al.Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:289–295.CrossRefGoogle ScholarPubMed
12.Chouinard, G. Sertraline in the treatment of obsessive-compulsive disorder. Two double blind placebo-controlled studies. Int Clin Psychopharmacol. 1992;7(Suppl. 2):37–41.Google Scholar
13.Zohar, J, Judge, R. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br J Psychiatry. 1996;169:468–474.Google Scholar
14.Flament, MF, Rapoport, JL, Berg, CJ. Clomipramine treatment of childhood OCD: a double-blind controlled study. Arch Gen Psychiatry. 1985;42:977–983.Google Scholar
15.Marks, IM, Lelliott, P, Basoglu, M, et al.Clomipramine, self exposure and therapist aided exposure for obsessive compulsive rituals. Br J Psychiatry. 1988;152;522–534.CrossRefGoogle ScholarPubMed
16.Mavissakalian, M, Jones, B, Olson, S, Perel, J. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels. J Clin Psychopharmacol. 1990;10:261–268.Google Scholar
17.De Veaugh Geiss, J, Katz, RJ, Landau, P, et al.Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48:730–738.Google Scholar
18.De Veaugh Geiss, J, Moroz, G, Biederman, J, et al.Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicentre trial. J Am Acad Child Adolesc Psychiatr. 1992;31:45–49.CrossRefGoogle Scholar
19.Pigott, TA, Pato, M, Bernstein, SE, et al.Controlled comparison of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1990;47:926–932.Google Scholar
20.Freeman, CP, Trimble, MR, Deakin, JFW, et al.Fluvoxamine or clomipramine in the treatment of obsessive-compulsive disorder? A multicenter, randomized double-blind, parallel group comparison. J Clin Psychiat. 1994;55,301–305.Google Scholar
21.Koran, LM, McElroy, SL, Davidson, JRT, Rasmussen, SA, Hollander, E, Jenike, MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychiat. 1996;16:121–129.Google Scholar
22.Milanfranchi, A, Ravagli, S, Lensi, P, Marazziti, D, Cassano, GB. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 1997;12:131–136.Google Scholar
23.Smeraldi, E, Erzegovesi, S, Bianchi, I, et al.Fluvoxamine v. clomipramine treatment in obsessive-compulsive disorder: a preliminary study. New Trends Exp Clin Psych. 1992;8:63–65.Google Scholar
24.Bisserbe, JC, Lane, RM, Flament, MF. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder. Eur Psychiat. 1997;12:82–93.Google Scholar
25.Greist, JH, Jefferson, JW, Kozak, KA, et al.A one year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995;10:57–65.Google Scholar
26.Hiss, H, Foa, E, Kozak, MJ. Relapse prevention program in the treatment of obsessive-compulsive disorder. J Consult Clin Psychol. 1994;62:801–808.Google Scholar
27.Leonard, HL, Swedo, SE, Rapoport, JL, Coffey, M, Cheslow, DL. Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double blind crossover comparison. Psychopharm Bull. 1988;24:93–95.Google Scholar
28.Riddle, MA, Scahill, L, King, RA, et al.Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatr. 1992;31:1062–1069.CrossRefGoogle ScholarPubMed
29.Goodman, WK, Price, LH, Delgado, PL, et al.Specificity of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder: comparison of fluvoxamine and desipramine. Arch Gen Psychiatry. 1990;47:577–585.Google Scholar
30.Zohar, J, Insel, TR. Obsessive compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biol Psychiatry 1987;22:667–687.Google Scholar
31.Ananth, JV, Pecknold, JC, Van den Steen, N, Engelsmann, F. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharm Biol Psychiat. 1981;5:257–262.Google Scholar
32.Montgomery, SA, Fineberg, NA, Montgomery, DB, Bullock, T. L-Tryptophan in obsessive compulsive disorder—a placebo controlled study. Eur Neuropsychopharmacol. 1992;2(Suppl. 2):384.Google Scholar
33.Insel, TR, Murphy, DL, Cohen, RM, Alterman, I, Kilts, C, Linnoila, M. Obsessive compulsive disorder—a double blind trial of clomipramine and clorgyline. Arch Gen Psychiatry. 1983;40:605–612.Google Scholar
34.Vallejo, J, Olivares, J, Marcos, T, Bulbena, A, Menchon, JM. Clomipramine versus phenelzine in obsessive compulsive disorder. A controlled clinical trial. Br J Psychiatry. 1992;161:665–670.CrossRefGoogle ScholarPubMed
35.Hewlett, WA, Vinogradov, S, Agras, WS. Clomipramine, clonazepam, and clonidine treatment of obsessive compulsive disorder. J Clin Psychopharmacol. 1992;12:420–430.CrossRefGoogle ScholarPubMed
36.Ravizza, L, Barzega, G, Bellino, S, et al.Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder. Psychopharm Bull. 1996;32:677–682.Google Scholar
37.Grady, TA, Pigott, TA, L'Heureux, F, Hill, JL, Bernstein, SE, Murphy, DL. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive compulsive disorder. Am J Psychiatry. 1993;150:819–821.Google Scholar
38.Lindsay, M, Craig, R, Andrews, G. Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiat. 1997;171:135–139.Google Scholar